Integrative multi-omics and drug response profiling of childhood acute lymphoblastic leukemia cell lines

Acute lymphoblastic leukemia (ALL) is the most common childhood cancer. Although standard-of-care chemotherapeutics are sufficient for most ALL cases, there are subsets of patients with poor response who relapse in disease. The biology underlying differences between subtypes and their response to th...

Descripción completa

Detalles Bibliográficos
Autores principales: Leo, Isabelle Rose, Aswad, Luay, Stahl, Matthias, Kunold, Elena, Post, Frederik, Erkers, Tom, Struyf, Nona, Mermelekas, Georgios, Joshi, Rubin Narayan, Gracia-Villacampa, Eva, Östling, Päivi, Kallioniemi, Olli P., Tamm, Katja Pokrovskaja, Siavelis, Ioannis, Lehtiö, Janne, Vesterlund, Mattias, Jafari, Rozbeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967900/
https://www.ncbi.nlm.nih.gov/pubmed/35354797
http://dx.doi.org/10.1038/s41467-022-29224-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967900/
https://www.ncbi.nlm.nih.gov/pubmed/35354797
http://dx.doi.org/10.1038/s41467-022-29224-5

Ejemplares similares